The discovery of hepcidin approximately 20 years ago has shed light on iron metabolism and provided evidence for improving current therapies, such as intermittent oral iron supplementation and prioritizing anti-inflammatory therapy in patients with functional iron deficiency or anemia of chronic disease [[26], [27], [28],79]. The gene discussed is HAMP; the disease is anemia (phenotype).